We cannot exclude the possibility that ELOVL5 methylation confers selective advantages to CRC cells, but to study this a large cohort of CRC would be required with information on DNA methylation status and survival and preferably also microsatellite instability status. The gene discussed is ELOVL5; the disease is colorectal carcinoma.